印度监管者在最近的测试中发现111个药物样本低于标准,2个是虚假的。 Indian regulators found 111 drug samples substandard and two spurious in recent tests.

中央毒品标准控制组织(CDSCO)在11月发现了111个“不达到标准质量”的毒品样品,其中41个来自中央实验室,70个来自州实验室。 Central Drugs Standard Control Organisation (CDSCO) found 111 drug samples "not of standard quality" in November, with 41 from central labs and 70 from state labs. 这些样品未能进行特定的质量测试,但问题仅限于经过测试的批次。 These samples failed specific quality tests, but the issues were confined to the tested batches. 还查明了两个虚假的毒品样品,这些样品是由未经授权的实体使用品牌名称制作的。 Two spurious drug samples, made by unauthorized entities using brand names, were also identified. 国家监管机构采取监管行动,将这些药物从市场中清除出来。 Regulatory actions are taken with state regulators to remove these drugs from the market.